R. Pohjanvirta et al., MECHANISM BY WHICH 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD) REDUCESCIRCULATING MELATONIN LEVELS IN THE RAT, Toxicology, 107(2), 1996, pp. 85-97
We have previously shown that the prototype for halogenated aromatic h
ydrocarbons, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), diminishes se
rum melatonin concentration at the same dose in both the most TCDD-sus
ceptible (Long-Evans, Turku AB; L-E) and the most TCDD-resistant (Han/
Wistar, Kuopio; H/W) rat strain. The change developed within 24 h and
persisted for at least 28 days after TCDD exposure; was independent of
the time of day and was not associated with any morphological damage
to the pineal gland. In the present study, we investigated the mechani
sm of this endocrine effect. Despite a 40-50% decrease in circulating
melatonin levels, the pineal content of melatonin, serotonin and 5-hyd
roxyindole acetic acid remained unaltered and the rate-limiting enzyme
of pineal melatonin biosynthesis, N-acetyltransferase, displayed only
a relatively minor suppression in activity (30%) in TCDD-treated L-E
rats. Likewise, TCDD did not influence the ability of pineal glands fr
om L-E rats to synthesize and secrete melatonin in ex vivo or in vitro
experiments. TCDD accelerated the disappearance of exogeneous melaton
in from the serum in both rat strains. This enhancement probably did n
ot originate in the liver, because liver perfusion studies revealed th
at even control rat livers were capable of total melatonin clearance i
n spite of the fact that the melatonin concentration far exceeded phys
iological levels, Urine excretion of the normal main metabolite of mel
atonin, 6-hydroxymelatoninsulfate, was reduced by TCDD treatment in bo
th strains. This was accompanied by an altered HPLC pattern of metabol
ites, especially in H/W rats. We conclude that TCDD decreases serum me
latonin levels in rats by enhancing the peripheral, evidently extrahep
atic, metabolism of the hormone.